These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14662643)

  • 1. Clinical relevance of bleeding index.
    Oster G; Vera M
    Arch Intern Med; 2003 Dec 8-22; 163(22):2794; author reply 2794-5. PubMed ID: 14662643
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of thromboembolic disease: an overview.
    Westrich GH; Sánchez PM
    Instr Course Lect; 2002; 51():471-80. PubMed ID: 12064136
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of the clinical results of pentasaccharide in major orthopedic surgery.
    Turpie AG
    Haematologica; 2001 Nov; 86(11 Suppl 2):59-62. PubMed ID: 11926781
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
    Iorio A
    J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of venous thromboembolism after major orthopedic surgery: 'new' clinical trials for new antithrombotic agents.
    Mismetti P
    J Thromb Haemost; 2003 Dec; 1(12):2474-6. PubMed ID: 14675081
    [No Abstract]   [Full Text] [Related]  

  • 7. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    ten Cate H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615119
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of non clinical end-points in studies on the prevention of venous thromboembolism.
    Agnelli G
    Haematologica; 1999 Jun; 84 Suppl EHA-4():82-4. PubMed ID: 10907477
    [No Abstract]   [Full Text] [Related]  

  • 9. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Turpie AG; Bauer KA; Eriksson BI; Lassen MR
    Lancet; 2003 Nov; 362(9395):1582-3. PubMed ID: 14615120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evidence for thrombosis prophylaxis to high-risk patients].
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
    Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
    [No Abstract]   [Full Text] [Related]  

  • 11. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
    Bounameaux H
    Lancet; 2003 Nov; 362(9395):1581; author reply 1582. PubMed ID: 14615118
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries for patients. Occurrence of venous thromboembolism in women taking low-dose aspirin.
    Ann Intern Med; 2007 Oct; 147(8):I34. PubMed ID: 17938386
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery.
    Kistler U; Kramers-de Quervain I; Munzinger U; Kucher N
    Thromb Haemost; 2008 Jun; 99(6):1049-52. PubMed ID: 18521507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis of venous thromboembolism].
    Wille-Jørgensen PA; Schroeder TV
    Ugeskr Laeger; 2000 Mar; 162(11):1523. PubMed ID: 10868103
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
    Verhaeghe R
    Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.
    Dahl OE
    Thromb Res; 2012 Oct; 130 Suppl 1():S32. PubMed ID: 23026656
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry.
    Arcelus JI; Monreal M; Caprini JA; Guisado JG; Soto MJ; Núñez MJ; Alvárez JC;
    Thromb Haemost; 2008 Mar; 99(3):546-51. PubMed ID: 18327403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Summary and perspectives. Rivaroxaban].
    Albaladejo P
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S28-31. PubMed ID: 19185785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative thrombosis prophylaxis--where are we going?].
    Jørgensen LN; Wille-Jørgensen P
    Ugeskr Laeger; 2005 May; 167(21):2259. PubMed ID: 15962849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.